ROR1 and Lyn are important regulators of signaling pathways driving CLL (Contri et al., 2005; Baskar et al., 2008; Fukuda et al., 2008; Nguyen et al., 2016) and several lymphomas, namely MCL (Karvonen et al., 2017a). Here, LYN is linked to lymphoma.